Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma
Simple Summary
- Supplementary File 1:
PDF-Document (PDF, 782 KiB)
Veeraraghavan, H.; Vargas, H.A.; Jimenez-Sanchez, A.; Micco, M.; Mema, E.; Lakhman, Y.; Crispin-Ortuzar, M.; Huang, E.P.; Levine, D.A.; Grisham, R.N.; Abu-Rustum, N.; Deasy, J.O.; Snyder, A.; Miller, M.L.; Brenton, J.D.; Sala, E. Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma. Cancers 2020, 12, 3403. https://doi.org/10.3390/cancers12113403
Veeraraghavan H, Vargas HA, Jimenez-Sanchez A, Micco M, Mema E, Lakhman Y, Crispin-Ortuzar M, Huang EP, Levine DA, Grisham RN, Abu-Rustum N, Deasy JO, Snyder A, Miller ML, Brenton JD, Sala E. Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma. Cancers. 2020; 12(11):3403. https://doi.org/10.3390/cancers12113403
Chicago/Turabian StyleVeeraraghavan, Harini, Herbert A. Vargas, Alejandro Jimenez-Sanchez, Maura Micco, Eralda Mema, Yulia Lakhman, Mireia Crispin-Ortuzar, Erich P. Huang, Douglas A. Levine, Rachel N. Grisham, Nadeem Abu-Rustum, Joseph O. Deasy, Alexandra Snyder, Martin L. Miller, James D. Brenton, and Evis Sala. 2020. "Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma" Cancers 12, no. 11: 3403. https://doi.org/10.3390/cancers12113403